why choose us

First received: February 08, 2023

Clinical Trial: Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Gastroesophageal Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) - a Phase Ib Feasibility Trial

Brief Summary: This is a phase 1b prospective, single arm, open-label trial determining the efficacy and feasibility of using a ctDNA assay (test) result to help guide neoadjuvant chemotherapy in subjects with Stage IB, II or Stage III adenocarcinoma of the stomach or gastroesophageal junction (GEA).

Read more